Generating an analytical strategic plan and developing methods appropriately during process development will help ensure quality, safety and efficacy
Wednesday, November 20, 2024
Autologous CAR-T cell therapies have already proven effective in treating hematological cancers, spurring extensive research into their potential for a wider range of diseases.
Wednesday, November 20, 2024
For the successful delivery of functional genes to patients, recombinant adenoviral-associated vectors (AAVs) are the most established and leading platform for rare and severe human diseases.
Wednesday, November 20, 2024
The limitations of current preservation approaches are driving researchers toward new alternatives
Wednesday, November 06, 2024
Facilities that make cell and gene therapies require cleaning and disinfection strategies not found at other drug manufacturing sites
Wednesday, November 06, 2024
Evaluating the factors that would support or preclude the birth and expansion of biosimilar versions of CAR-T therapies
Thursday, October 31, 2024
The synergy between automated cell expansion systems and real-time analyzers creates a powerful combination for monitoring cell expansion processes
Wednesday, October 30, 2024